Plain-English translation of NCT07019766 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term research study that follows patients diagnosed with large granular lymphocytic leukemia (a rare type of blood cancer) over many years. Researchers will collect information about your medical history, test results, treatments, and health outcomes to better understand this disease and improve care for patients in China.
Large granular lymphocytic leukemia is a rare blood disease, and there is not enough large-scale, detailed information about how it develops, which treatments work best, and what happens to patients over time in China. This study aims to fill that gap by gathering comprehensive information that can help doctors treat future patients more effectively.
You likely qualify if…
You likely don't qualify if…
As a participant, you would allow researchers to review and collect your medical records, test results, and treatment history from the hospital. Over time, researchers may contact you to ask about your current health status, how you are doing, and any new treatments you have received. This is a registry-based study, meaning researchers are building a database of patient information rather than giving you a new medication to take.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
China